Drugs / CHF10073
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06746064 | Jan 2025 → Feb 2026 | pulmonary fibrosis | Chiesi Farmaceutici S.p.A. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CHF10073 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06746064 ↗ |
| Route | Inhaled | “Via inhalation” NCT06746064 ↗ |